PMID- 37111114 OWN - NLM STAT- MEDLINE DCOM- 20230501 LR - 20230919 IS - 2072-6643 (Electronic) IS - 2072-6643 (Linking) VI - 15 IP - 8 DP - 2023 Apr 14 TI - Association between Micronutrients and Hyperhomocysteinemia: A Case-Control Study in Northeast China. LID - 10.3390/nu15081895 [doi] LID - 1895 AB - Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular and cerebrovascular diseases where the plasma homocysteine (Hcy) concentration exceeds 15 micromol/L. HHcy is affected by vitamins B12, B6, and folic acid (fol); however, its relationship with other nutrients is not fully understood. We investigated the nutritional and genetic factors associated with HHcy and the possible dose-response relationships or threshold effects in patients in Northeast China. Genetic polymorphisms and micronutrients were tested with polymerase chain reaction and mass spectrometry, respectively. This trial was registered under trial number ChiCTR1900025136. The HHcy group had significantly more males and higher body mass index (BMI), methylenetetrahydrofolate reductase (MTHFR 677TT) polymorphism proportion, and uric acid, Zn, Fe, P, and vitamin A levels than the control group. After adjusting for age, sex, BMI, vitamin B12, fol, and MTHFR C677T, the lowest Zn quartile reduced the odds ratio of HHcy compared with the highest Zn quartile. The dose-response curves for the association between plasma Zn and HHcy were S-shaped. High plasma Zn concentrations were significantly correlated with high HHcy odds ratios, and the curve leveled off or slightly decreased. Most importantly, HHcy risk decreased with decreasing plasma Zn concentration; the threshold was 83.89 micromol/L. Conclusively, individuals residing in Northeast China, especially those with the MTHFR 677TT polymorphism, must pay attention to their plasma Zn and Hcy levels. FAU - Sun, Can AU - Sun C AD - Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang 110004, China. FAU - Ding, Ding AU - Ding D AD - Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang 110004, China. FAU - Wen, Zhouyu AU - Wen Z AD - Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang 110004, China. FAU - Zhang, Chengmei AU - Zhang C AD - Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang 110004, China. FAU - Kong, Juan AU - Kong J AD - Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang 110004, China. LA - eng GR - 82073545,81570811/National Natural Science Foundation of China/ GR - 2023/Strategic emerging disciplines program of China Medical University/ GR - M0465/the Clinical project support plan in ShengJing Hospital in 2019/ PT - Journal Article DEP - 20230414 PL - Switzerland TA - Nutrients JT - Nutrients JID - 101521595 RN - 0 (Micronutrients) RN - EC 1.5.1.20 (Methylenetetrahydrofolate Reductase (NADPH2)) RN - 935E97BOY8 (Folic Acid) RN - P6YC3EG204 (Vitamin B 12) RN - 0LVT1QZ0BA (Homocysteine) SB - IM MH - Male MH - Humans MH - Case-Control Studies MH - *Hyperhomocysteinemia MH - Micronutrients MH - Polymorphism, Genetic MH - Methylenetetrahydrofolate Reductase (NADPH2)/genetics MH - Folic Acid MH - Vitamin B 12 MH - Homocysteine/genetics MH - Genotype PMC - PMC10145750 OTO - NOTNLM OT - MTHFR C677T polymorphism OT - homocysteine OT - hyperhomocysteinemia OT - zinc COIS- The authors declare no conflict of interest. EDAT- 2023/04/28 06:41 MHDA- 2023/05/01 06:42 PMCR- 2023/04/14 CRDT- 2023/04/28 01:44 PHST- 2023/02/13 00:00 [received] PHST- 2023/04/04 00:00 [revised] PHST- 2023/04/12 00:00 [accepted] PHST- 2023/05/01 06:42 [medline] PHST- 2023/04/28 06:41 [pubmed] PHST- 2023/04/28 01:44 [entrez] PHST- 2023/04/14 00:00 [pmc-release] AID - nu15081895 [pii] AID - nutrients-15-01895 [pii] AID - 10.3390/nu15081895 [doi] PST - epublish SO - Nutrients. 2023 Apr 14;15(8):1895. doi: 10.3390/nu15081895.